SCHEMBL6172214

SCHEMBL6172214

Nc1nc(-c2ccc(NC(=O)CN(C(=O)c3ccc(F)cc3)c3ccc4c(c3)OCO4)cc2)cs1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 10/20 0.51
▸ TSHR P16473 4/20 0.51
▸ ALDH1A1 P00352 4/20 0.51
▸ GAA P10253 3/20 0.51
▸ HTT P42858 3/20 0.51
▸ LMNA P02545 2/20 0.51
▸ SMN1; SMN2 Q16637 3/20 0.46
▸ USP2 O75604 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ POLB P06746 3/20 0.44
▸ CASP3 P42574 1/20 0.44
▸ SENP8 Q96LD8 1/20 0.44
▸ SENP7 Q9BQF6 1/20 0.44
▸ SENP6 Q9GZR1 1/20 0.44
▸ KMT2A Q03164 6/20 0.43
▸ MEN1 O00255 4/20 0.43
▸ L3MBTL1 Q9Y468 3/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ TP53 P04637 1/20 0.42
▸ RAB9A P51151 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6174882 0.95 POLB (0.49) MAPTTSHRALDH1A1GAAHTT
Hydrochloric Acid SCHEMBL6175614 0.89 MAPT (0.49) MAPTTSHRALDH1A1GAAHTT
SCHEMBL6176759 0.89 RAB9A (0.57) MAPTTSHRALDH1A1GAAHTT
Hydrochloric Acid SCHEMBL6173338 0.87 RAB9A (0.50) MAPTALDH1A1GAALMNASMN1; SMN2
SCHEMBL27601341 0.87 MAPT (0.47) MAPTTSHRALDH1A1GAAHTT
SCHEMBL6174603 0.85 MAPT (0.53) MAPTTSHRALDH1A1GAAHTT
SCHEMBL27583802 0.84 KMT2A (0.48) MAPTALDH1A1GAALMNASMN1; SMN2
SCHEMBL6173268 0.84 RAB9A (0.43) MAPTALDH1A1GAASMN1; SMN2KDM4E
SCHEMBL27601320 0.83 MEN1 (0.48) MAPTALDH1A1GAAHTTLMNA
Hydrochloric Acid SCHEMBL6174792 0.83 MEN1 (0.48) MAPTALDH1A1GAAHTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6949543-B2 Amide derivative YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 2005-09-27 — — US claimed
EP-1340750-B1 AMIDE DERIVATIVES YAMANOUCHI PHARMA CO LTD (JP) 2005-08-17 — — EP claimed
US-20040034232-A1 Amide derivative ASTELLAS PHARMA INC. (JP) 2004-02-19 — — US claimed
CN-1473157-A Amide derivatives ֮����ҩ��ʽ���� 2004-02-04 — — CN claimed
EP-1340750-A1 AMIDE DERIVATIVES YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 2003-09-03 — — EP claimed
US-6949543-B2 Amide derivative YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 2005-09-27 — — US disclosed
EP-1340750-B1 AMIDE DERIVATIVES YAMANOUCHI PHARMA CO LTD (JP) 2005-08-17 — — EP disclosed
US-20040034232-A1 Amide derivative ASTELLAS PHARMA INC. (JP) 2004-02-19 — — US disclosed
CN-1473157-A Amide derivatives ֮����ҩ��ʽ���� 2004-02-04 — — CN disclosed
EP-1340750-A1 AMIDE DERIVATIVES YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 2003-09-03 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040034232-A1 Amide derivative HDAC2, ZC3HAV1, HDAC4 MAPT 1746/4885TSHR 2092/4885ALDH1A1 3774/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback